1. Otto CM, Nishimura RA, Bonow RO, 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143: e35-71.
2.
Praz F, Borger MA, Lanz J, et al. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2025; 46: 4635-736.
3.
Généreux P, Sharma RP, Cubeddu RJ, et al. The mortality burden of untreated aortic stenosis. J Am Coll Cardiol 2023; 82: 2101-9.
4.
Elbaz-Greener G, Masih S, Fang J, et al. Temporal trends and clinical consequences of wait times for transcatheter aortic valve replacement. Circulation 2018; 138: 483-93.
5.
Coisne A, Montaigne D, Aghezzaf S, et al. Association of mortality with aortic stenosis severity in outpatients. JAMA Cardiol 2021; 6: 1424-31.
6.
Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of transcatheter aortic valve replacement. J Am Coll Cardiol 2020; 76: 2492-516.
7.
Compagnone M, Dall’Ara G, Grotti S, et al. Transcatheter aortic valve replacement without on-site cardiac surgery. JACC Cardiovasc Interv 2023; 16: 3026-30.
8.
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43: 561-632.
9.
Egger F, Zweiker D, Freynhofer MK, et al. Impact of on-site cardiac surgery on clinical outcomes after transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018; 11: 2160-7.
10.
Urena M, Vahanian A, Iung B. Transcatheter aortic valve replacement without on-site cardiac surgery. JACC Cardiovasc Interv 2023; 16: 3031-3.
11.
Aarts HM, van Nieuwkerk AC, Hemelrijk KI, et al. Surgical bailout in patients undergoing transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv 2025; 18: 89-99.
12.
Eggebrecht H, Vaquerizo B, Moris C, et al. Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI). Eur Heart J 2018; 39: 676-84.
13.
Kobo O, Saada M, Roguin A. Can transcatheter aortic valve implantation (TAVI) be performed at institutions without on-site cardiac surgery departments? Cardiovasc Revasc Med 2022; 41: 159-65.
14.
Garrido JR, Mazuecos JJ, Sigismondi A, et al. Transfemoral TAVR at hospitals without on-site cardiac surgery department in Spain. JACC Cardiovasc Interv 2019; 12: 896-8.
15.
Eggebrecht H, Berstehorn M, Haude M, et al. Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart J 2016; 37: 2240-8.
16.
Egger F, Zweiker D, Freynhofer MK, et al. Impact of on-site cardiac surgery on clinical outcomes after transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018; 11: 2160-7.
17.
Brooke BS, Schwartz TA, Pawlik TM. MOOSE reporting guidelines for meta-analyses of observational studies. JAMA Surg 2021; 156: 787-8.
18.
Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919.
19.
Bartuś S, Dziewierz A. Transcatheter aortic valve implantation without on-site surgical backup: is it time for Poland to embrace the paradigm shift? Adv Interv Cardiol 2025; 21: 291-4.
20.
Giordano A, Corcione N, Barbanti M, et al. Features and outcomes of bailout repeat transcatheter aortic valve implantation (TAVI): the Bailout Acute TAVI-in-TAVI to Lessen Events (BATTLE) international registry. Clin Res Cardiol 2024; 113: 68-74.